Please assess the completion status of the following clinical trial:

Trial Title: RCT: Triple vs Sequential vs Concomitant Therapy H Pylori

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* consecutive patients newly diagnosed to have H. pylori infection.~Exclusion Criteria:~* known allergy to any of the treatment drugs~* inability to undergo routine test to confirm success of H. pylori eradication~* previous H. pylori therapy.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- triple therapy (Type: ACTIVE_COMPARATOR): 10 day triple therapy (PPI, amoxicillin 1g, clarithromycin 500mg twice daily)
- Concomitant therapy (Type: ACTIVE_COMPARATOR): 10-day concomitant therapy (PPI, amoxicillin 1g, clarithromycin 500mg, metronidazole 400mg twice daily).
- sequential therapy (Type: ACTIVE_COMPARATOR): 10-day sequential therapy (PPI and amoxicillin 1 g twice daily x 5 days followed by PPI, clarithromycin 500mg, metronidazole 400mg twice daily x 5days)

Based on this trial design, predict the completion outcome and termination type (if applicable).